Tonix Pharmaceuticals (TNXP) Continues to Rally after licensing Technology for Willi Syndrome
Ali Hassan
February 12, 2021
Tonix has licensed technology from the French National Institute of Health and Medical Research (Inserm). Shares of Tonix Pharmaceuticals (TNXP) have since the start of